Digital Health Applications & Devices: Where the FDA Provides Oversight & Where It Doesn’t
The FDA has solidified its stance of focusing on high-risk digital health tools. Read about the wider scope of the FDA’s released guidance on health care technology.
Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.
December 2019 MRC2.CORP.X.04073